RE: women and girls in Science day12 Feb 2020 05:00
Morning All,
That is one phenomanal list of publications over 40 years.
I often wonder going back to the early days how difficult it must have been, with Lindy sharing her time woth Nottingham University and just a handful of staff, after all in the submission to AIM document we were to trial SCIB1 and sell her to the highest bidder.
With the serendipity discovery of Moditope along with so many advances in the Oncology Industry, we now have a staff of 23 with 12 PhDs, a SCIB1 Combo Trial Approved by the FDA and a 25 patient trial which I can only imagine will start A.S.A.P., A SCIB2 Trial being paid for by CRUK, awaiting trial dates, MOD1 at last going to trials, my guess early Q1 2021, A TCR/Glycans platform and Avidamab with three collaborations going.
So from acorns grow........................and we have sure heard some very derogatary remarks aimed at the BOD for ""delays"". I am sure many of us know how long it takes to build a business, and common sense tells us how long a Biotech takes too.
I am grateful, as with most things in my life, that we are here now, platforms converging together to reach human trials and the very real prospects of Commercial Deals to come from TCRs and Avidamab too.
Just 230k traded this week 36k sells and we are up 7%, the bid was fidgeting yesterday up to 7.111 for 180k, lets have another blue day today, this is indeed is a Pivotal Year.
Have a great day all................